{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:09:06Z","timestamp":1790284146324,"version":"4.1.0"},"reference-count":109,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01551","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T04:34:09Z","timestamp":1547094849000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Inhibition of Soluble Epoxide Hydrolase for Renal Health"],"prefix":"10.3389","volume":"9","author":[{"given":"Jun-Yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1134\/S0026893313060022","article-title":"Elevated expression of the Ephx2 mRNA in the kidney of hypertensive ISIAH rats.","volume":"47","author":"Abramova","year":"2013","journal-title":"Mol. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.7868\/S0026898417020021","article-title":"Increase in the concentration of sEH protein in renal medulla of ISIAH rats with inherited stress-induced arterial hypertension.","volume":"51","author":"Abramova","year":"2017","journal-title":"Mol. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.dsx.2016.08.019","article-title":"Increased renal resistive index in type 2 diabetes: clinical relevance, mechanisms and future directions.","volume":"11","author":"Afsar","year":"2017","journal-title":"Diabetes Metab. Syndr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1161\/01.CIR.0000047278.28407.C2","article-title":"Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BKCa channels.","volume":"107","author":"Archer","year":"2003","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"15265","DOI":"10.1074\/jbc.M000278200","article-title":"Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation.","volume":"275","author":"Argiriadi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.1073\/pnas.96.19.10637","article-title":"Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase.","volume":"96","author":"Argiriadi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1111\/febs.14100","article-title":"Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury.","volume":"284","author":"Bettaieb","year":"","journal-title":"FEBS J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1016\/j.bbagen.2017.07.021","article-title":"Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.","volume":"1861","author":"Bettaieb","year":"","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.chemosphere.2010.11.018","article-title":"A review of personal care products in the aquatic environment: environmental concentrations and toxicity.","volume":"82","author":"Brausch","year":"2011","journal-title":"Chemosphere"},{"key":"B10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jhazmat.2013.08.040","article-title":"Pharmaceuticals and personal care products in the aquatic environment in China: a review.","volume":"262","author":"Bu","year":"2013","journal-title":"J. Hazard. Mater."},{"key":"B11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/01.RES.78.3.415","article-title":"Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.","volume":"78","author":"Campbell","year":"1996","journal-title":"Circ. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/1440-1681.12419","article-title":"Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.","volume":"42","author":"Cervenka","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000487902","article-title":"Combined inhibition of soluble epoxide hydrolase and renin-angiotensin system exhibits superior renoprotection to renin-angiotensin system blockade in 5\/6 nephrectomized Ren-2 transgenic hypertensive rats with established chronic kidney disease.","volume":"43","author":"Ch\u00e1bov\u00e1","year":"2018","journal-title":"Kidney Blood Press. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/0091270010397049","article-title":"Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects.","volume":"52","author":"Chen","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"E563","DOI":"10.1152\/ajpendo.00591.2011","article-title":"Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.","volume":"303","author":"Chen","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/jth.14235","article-title":"Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study.","volume":"16","author":"Cheung","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/693260","article-title":"Genetic deletion of soluble epoxide hydrolase attenuates inflammation and fibrosis in experimental obstructive nephropathy.","volume":"2015","author":"Chiang","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1681\/ASN.2011010026","article-title":"AMPK mediates the initiation of kidney disease induced by a high-fat diet.","volume":"22","author":"Decleves","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"12608","DOI":"10.1073\/pnas.1705615114","article-title":"Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3 beta signaling.","volume":"114","author":"Deng","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B20","doi-asserted-by":"crossref","first-page":"A123","DOI":"10.1096\/fasebj.20.4.A123-b","article-title":"Epoxyeicosatrienoic acids (EETs) protect cardiovascular cells from apoptosis mediated by caspase 3-dependent pathways.","volume":"20","author":"Dhanasekaran","year":"2006","journal-title":"FASEB J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.amjhyper.2005.04.019","article-title":"The prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.","volume":"18","author":"Dreisbach","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00467-011-1938-2","article-title":"Investigating mechanisms of chronic kidney disease in mouse models.","volume":"27","author":"Eddy","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1208\/s12248-012-9425-7","article-title":"Determination of the dominant arachidonic acid cytochrome P450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics.","volume":"15","author":"El-Sherbeni","year":"2013","journal-title":"AAPS J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1369\/jhc.5A6808.2005","article-title":"Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues.","volume":"54","author":"Enayetallah","year":"2006","journal-title":"J. Histochem. Cytochem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/002215540405200403","article-title":"Distribution of soluble epoxide hydrolase and of cytochrome P4502C8, 2C9, and 2J2 in human tissues.","volume":"52","author":"Enayetallah","year":"2004","journal-title":"J. Histochem. Cytochem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/MNH.0000000000000088","article-title":"Cytochrome P450 eicosanoids in hypertension and renal disease.","volume":"24","author":"Fan","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00467-007-0524-0","article-title":"Mechanisms of progression of chronic kidney disease.","volume":"22","author":"Fogo","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133563","article-title":"A 3\u2032 -UTR polymorphism in soluble epoxide hydrolase gene is associated with acute rejection in renal transplant recipients.","volume":"10","author":"Gervasini","year":"2015","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jclinane.2014.09.011","article-title":"New insights into the mechanisms of acute kidney injury in the intensive care unit.","volume":"27","author":"Glodowski","year":"2015","journal-title":"J. Clin. Anesth."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1021\/bi036189j","article-title":"Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis.","volume":"43","author":"Gomez","year":"2004","journal-title":"Biochemistry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2131\/jts.40.451","article-title":"Change in soluble epoxide hydrolase (sEH) during cisplatin-induced acute renal failure in mice.","volume":"40","author":"Hashimoto","year":"2015","journal-title":"J. Toxicol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/1753-0407.12358","article-title":"Soluble epoxide hydrolase: a potential target for metabolic diseases.","volume":"8","author":"He","year":"2016","journal-title":"J. Diabetes"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-018-1402-4","article-title":"Oxylipin profiling of human plasma reflects the renal dysfunction in uremic patients.","volume":"14","author":"Hu","year":"2018","journal-title":"Metabolomics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"F342","DOI":"10.1152\/ajprenal.00004.2007","article-title":"Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats.","volume":"293","author":"Huang","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/HYPERTENSIONAHA.114.03585","article-title":"Epoxyeicosatrienoic acids, hypertension, and kidney injury.","volume":"65","author":"Imig","year":"2015","journal-title":"Hypertension"},{"key":"B36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/ph2030217","article-title":"The soluble epoxide hydrolase inhibitor AR9281 decreases blood pressure, ameliorates renal injury and improves vascular function in hypertension.","volume":"2","author":"Imig","year":"2009","journal-title":"Pharmaceuticals"},{"key":"B37","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.","volume":"8","author":"Imig","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1258\/ebm.2012.012225","article-title":"Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor gamma agonist improve vascular function and decrease renal injury in hypertensive obese rats.","volume":"237","author":"Imig","year":"2012","journal-title":"Exp. Biol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/hy0202.103788","article-title":"Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.","volume":"39","author":"Imig","year":"2002","journal-title":"Hypertension"},{"key":"B40","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1161\/01.HYP.0000176237.74820.75","article-title":"An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.","volume":"46","author":"Imig","year":"2005","journal-title":"Hypertension"},{"key":"B41","doi-asserted-by":"publisher","first-page":"18901","DOI":"10.1073\/pnas.0809765105","article-title":"Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways.","volume":"105","author":"Inceoglu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1517\/14656566.2010.496453","article-title":"Sorafenib: a clinical and pharmacologic review.","volume":"11","author":"Iyer","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s002040050250","article-title":"Tissue-specific basal expression of soluble murine epoxide hydrolase and effects of clofibrate on the messenger-rna levels in extrahepatic tissues and liver.","volume":"70","author":"Johansson","year":"1995","journal-title":"Arch. Toxicol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011979","article-title":"Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease.","volume":"5","author":"Jung","year":"2010","journal-title":"PLoS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.prostaglandins.2016.08.004","article-title":"Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.","volume":"132","author":"Katary","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B46","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.bmcl.2013.12.020","article-title":"Discovery of 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating of chronic kidney diseases.","volume":"24","author":"Kato","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"F971","DOI":"10.1152\/ajprenal.00256.2014","article-title":"Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.","volume":"307","author":"Kim","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"F131","DOI":"10.1152\/ajprenal.00531.2014","article-title":"Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.","volume":"308","author":"Kim","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"E691","DOI":"10.1152\/ajpendo.00710.2010","article-title":"Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats.","volume":"300","author":"Koeners","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B50","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1159\/000339883","article-title":"Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension.","volume":"35","author":"Kopkan","year":"2012","journal-title":"Kidney Blood Press. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/1440-1681.12204","article-title":"Inhibition of soluble epoxide hydrolase is renoprotective in 5\/6 nephrectomized Ren-2 transgenic hypertensive rats.","volume":"41","author":"Kujal","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/apha.12089","article-title":"Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury.","volume":"208","author":"Kusch","year":"2013","journal-title":"Acta Physiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/BF00225209","article-title":"Localization of the human soluble epoxide hydrolase gene (Ephx2) to chromosomal region 8p21-P12.","volume":"95","author":"Larsson","year":"1995","journal-title":"Hum. Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/bcp.12855","article-title":"Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor.","volume":"81","author":"Lazaar","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"F1283","DOI":"10.1152\/ajprenal.00733.2010","article-title":"In vivo activity of epoxide hydrolase according to sequence variation affects the progression of human IgA nephropathy.","volume":"300","author":"Lee","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.transproceed.2008.03.137","article-title":"Genetic variations in soluble epoxide hydrolase and graft function in kidney transplantation.","volume":"40","author":"Lee","year":"2008","journal-title":"Transplant. Proc."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094092","article-title":"Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"B58","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbrc.2015.05.020","article-title":"Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3 beta signaling pathway.","volume":"463","author":"Liang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B59","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/jdi.12230","article-title":"From sugar to kidney: a never-ending battle.","volume":"5","author":"Lin","year":"2014","journal-title":"J. Diabetes Investig."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1158\/1535-7163.MCT-09-0119","article-title":"Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo.","volume":"8","author":"Liu","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.taap.2011.06.017","article-title":"Inhibition of soluble epoxide hydrolase contributes to the anti-inflammatory effect of antimicrobial triclocarban in a murine model.","volume":"255","author":"Liu","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1124\/mol.113.088302","article-title":"Epoxyeicosatrienoic acids prevent cisplatin-induced renal apoptosis through a p38 mitogen-activated protein kinase-regulated mitochondrial pathway.","volume":"84","author":"Liu","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1124\/jpet.111.191247","article-title":"Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor kappa B signaling.","volume":"341","author":"Liu","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2786470","article-title":"Association of EPHX2 R287Q polymorphism with diabetic nephropathy in Chinese type 2 diabetic patients.","volume":"2018","author":"Ma","year":"2018","journal-title":"J. Diabetes Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.cca.2010.06.019","article-title":"Mechanism of endothelial dysfunction in chronic kidney disease.","volume":"411","author":"Malyszko","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/749812","article-title":"Signaling mechanisms in the regulation of renal matrix metabolism in diabetes.","volume":"2012","author":"Mariappan","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/jhh.2013.55","article-title":"Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage.","volume":"28","author":"Mennuni","year":"2014","journal-title":"J. Hum. Hypertens."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2180373","article-title":"Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome.","volume":"2018","author":"Mihai","year":"2018","journal-title":"J. Immunol. Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2741\/4585","article-title":"Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease.","volume":"23","author":"Moradi","year":"2018","journal-title":"Front. Biosci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health.","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2004.10.001","article-title":"Epoxide hydrolases: their roles and interactions with lipid metabolism.","volume":"44","author":"Newman","year":"2005","journal-title":"Prog. Lipid Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2174\/157488406778249325","article-title":"Sorafenib (BAY 43-9006): review of clinical development.","volume":"1","author":"Ng","year":"2006","journal-title":"Curr. Clin. Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1007\/s10495-007-0123-3","article-title":"Epoxyeicosatrienoic acids induce growth inhibition and calpain\/caspase-12 dependent apoptosis in PDGF cultured 3T6 fibroblast.","volume":"12","author":"Nieves","year":"2007","journal-title":"Apoptosis"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"B75","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2133\/dmpk.24.438","article-title":"Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: high glucose suppresses sEH expression.","volume":"24","author":"Oguro","year":"2009","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B76","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1042\/CS20080039","article-title":"Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.","volume":"116","author":"Olearczyk","year":"2009","journal-title":"Clin. Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10565-008-9071-0","article-title":"Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase.","volume":"25","author":"Parrish","year":"2009","journal-title":"Cell Biol. Toxicol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0006-2952(86)90519-8","article-title":"Subcellular-localization of epoxide hydrolase in mouse-liver and kidney.","volume":"35","author":"Patel","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/apha.12063","article-title":"Mechanisms of acute kidney injury.","volume":"207","author":"Persson","year":"2013","journal-title":"Acta Physiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pharmthera.2016.07.011","article-title":"Mechanisms of triple whammy acute kidney injury.","volume":"167","author":"Prieto-Garcia","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/jnr.21827","article-title":"Differential subcellular distribution and colocalization of the microsomal and soluble epoxide hydrolases in cultured neonatal rat brain cortical astrocytes.","volume":"87","author":"Rawal","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1172\/JCI27699","article-title":"Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.","volume":"116","author":"Remuzzi","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B83","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.prostaglandins.2015.04.011","article-title":"Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.","volume":"120","author":"Roche","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B84","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/HJH.0000000000001599","article-title":"Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: general mechanisms: a joint consensus statement from the European society of hypertension working group on endothelin and endothelial factors and the Japanese society of hypertension.","volume":"36","author":"Rossi","year":"2018","journal-title":"J. Hypertens."},{"key":"B85","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1006\/bbrc.1996.0596","article-title":"Structural characterization of the human soluble epoxide hydrolase gene (EPHX2).","volume":"221","author":"Sandberg","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B86","doi-asserted-by":"publisher","first-page":"F552","DOI":"10.1152\/ajprenal.00354.2004","article-title":"Differential renal gene expression in prehypertensive and hypertensive spontaneously hypertensive rats.","volume":"289","author":"Seubert","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17050751","article-title":"Novel Omega-3 fatty acid epoxygenase metabolite reduces kidney fibrosis.","volume":"17","author":"Sharma","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175292","article-title":"Association of gain-of-function EPHX2 polymorphism Lys55Arg with acute kidney injury following cardiac surgery.","volume":"12","author":"Shuey","year":"2017","journal-title":"PLoS One"},{"key":"B89","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1073\/pnas.1221972110","article-title":"Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis.","volume":"110","author":"Sirish","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B90","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/onc.2008.362","article-title":"CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations.","volume":"28","author":"Smalley","year":"2009","journal-title":"Oncogene"},{"key":"B91","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","article-title":"Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.","volume":"43","author":"Spector","year":"2004","journal-title":"Prog. Lipid Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"C996","DOI":"10.1152\/ajpcell.00402.2006","article-title":"Action of epoxyeicosatrienoic acids on cellular function.","volume":"292","author":"Spector","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"R1468","DOI":"10.1152\/ajpregu.00215.2010","article-title":"Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats.","volume":"300","author":"Sporkova","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.3390\/ijms16034744","article-title":"Transcriptome analysis in rat kidneys: importance of genes involved in programmed hypertension.","volume":"16","author":"Tain","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000448081","article-title":"Insights into the mechanisms of the acute kidney injury-to-chronic kidney disease continuum.","volume":"134","author":"Takaori","year":"2016","journal-title":"Nephron"},{"key":"B96","year":"2009","journal-title":"USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States"},{"key":"B97","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/HJH.0b013e328334dfd4","article-title":"Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats.","volume":"28","author":"Walkowska","year":"2010","journal-title":"J. Hypertens."},{"key":"B98","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1172\/JCI61453","article-title":"Epoxyeicosatrienoic acids: a double-edged sword in cardiovascular diseases and cancer.","volume":"122","author":"Wang","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B99","doi-asserted-by":"publisher","first-page":"F915","DOI":"10.1152\/ajprenal.00534.2017","article-title":"Expression of soluble epoxide hydrolase in renal tubular epithelial cells regulates macrophage infiltration and polarization in IgA nephropathy.","volume":"315","author":"Wang","year":"2018","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"F168","DOI":"10.1152\/ajprenal.00129.2012","article-title":"Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage.","volume":"304","author":"Wang","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling.","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"B102","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int."},{"key":"B103","doi-asserted-by":"publisher","first-page":"329","DOI":"10.23876\/j.krcp.2017.36.4.329","article-title":"Active maintenance of endothelial cells prevents kidney fibrosis.","volume":"36","author":"Yang","year":"2017","journal-title":"Kidney Res. Clin. Pract."},{"key":"B104","doi-asserted-by":"publisher","first-page":"F720","DOI":"10.1152\/ajprenal.00165.2003","article-title":"Vascular localization of soluble epoxide hydrolase in the human kidney.","volume":"286","author":"Yu","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","article-title":"Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.","volume":"87","author":"Yu","year":"2000","journal-title":"Circ. Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1006\/abbi.1995.1059","article-title":"Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase - substrate structural determinants of asymmetric catalysis.","volume":"316","author":"Zeldin","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"B107","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1089\/hum.2011.135","article-title":"Delivery of AAV2-CYP2J2 protects remnant kidney in the 5\/6-nephrectomized rat via inhibition of apoptosis and fibrosis.","volume":"23","author":"Zhao","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"B108","first-page":"1244","article-title":"Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.","volume":"15","author":"Zhao","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145645","article-title":"Renal ischemia\/reperfusion injury in soluble epoxide hydrolase-deficient mice.","volume":"11","author":"Zhu","year":"2016","journal-title":"PLoS One"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01551\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T01:07:58Z","timestamp":1662772078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01551\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":109,"alternative-id":["10.3389\/fphar.2018.01551"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01551","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"article-number":"1551"}}